Back to all AI Solutions
AVIEW - LCS+
One-stop CT scan solution for detecting Big 3 diseases (lung cancer, COPD, CVD) that co-exist in early stage from a single CT scan. In addition, aview LCS Plus provides emphysema analysis and coronary artery calcium score.
Key benefits
- Sensitivity 97%, Specificity 76% at 1-FP/scan
- ROC AUC 0.93
- LungRADS score according to LungRADS 1.1 guideline
Details
- Regulatory:
CE
FDA
CT
Lungs
Oncology
Cardiology
- Clinical Applications:
CE
FDA
CT
Lungs
Oncology
Cardiology
- Modality:
CE
FDA
CT
Lungs
Oncology
Cardiology
- Body Part:
CE
FDA
CT
Lungs
Oncology
Cardiology
Peer-reviewed publications
- Low-dose CT for lung cancer screening: position paper from the Italian college of thoracic radiology. Read
- Outstanding negative prediction performance of solid pulmonary nodule volume AI for ultra-LDCT baseline lung cancer screening risk stratification. Read
- Feasibility of implementing a national lung cancer screening program: Interim results from the Korean Lung Cancer Screening Project (K-LUCAS). Read
